SCHEMBL7664149

SCHEMBL7664149

CC(=O)On1c(=O)c(-c2cn(CCCN)c3ccccc23)nc2cc3c(cc21)CCCC3

nearest known ligand 0.41

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
CAMK2D Q13557 16/20 0.41
PIM1 P11309 1/20 0.40
KDR P35968 1/20 0.39
GSK3B P49841 1/20 0.39
RPS6KB1 P23443 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7665495 0.98 CAMK2D (0.41) CAMK2DPIM1KDRGSK3BRPS6KB1
SCHEMBL7657124 0.97 CAMK2D (0.39) CAMK2DPIM1KDRGSK3B
SCHEMBL7663936 0.96 CAMK2D (0.39) CAMK2DPIM1KDRGSK3B
SCHEMBL7666393 0.90 CAMK2D (0.36) CAMK2DGSK3B
SCHEMBL7662560 0.90 PDE4B (0.40) GSK3B
SCHEMBL7653829 0.89 CNR2 (0.36) CAMK2DGSK3B
SCHEMBL7657954 0.88 MAOB (0.38) KDR
SCHEMBL7662842 0.88 PDE4B (0.40) GSK3B
SCHEMBL7663917 0.88 PDE4A (0.38)
SCHEMBL7663926 0.87 CNR1 (0.37) KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6458792-B1 MEDICAMENT FOR THE TREATMENT OF INFLAMMATORY, IMMUNOLOGICAL, BRONCHOPULMONARY, CARDIOVASCULAR, ONCOLOGICAL OR CNS-DEGENERATIVE DISORDERS. ASTRAZENECA AB (SE) 2002-10-01 US disclosed
EP-1071683-A1 NEW COMPOUNDS AstraZeneca AB (SE) 2001-01-31 EP disclosed
WO-1999046264-A1 NEW COMPOUNDS ASTRAZENECA AB (SE) 1999-09-16 WO disclosed